Targeting Global Leadership in Decentralized Water & Wastewater Treatment Solutions - Fluence Corporation (ASX: FLC) Corporate Overview August 2019
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
www.fluencecorp.com Targeting Global Leadership in Decentralized Water & Wastewater Treatment Solutions Fluence Corporation (ASX: FLC) Corporate Overview August 2019
Executive Summary • A leading water and wastewater treatment solutions provider focused exclusively on the decentralized US$M market – Over 7,000 installations in over 70 countries • Global water scarcity and contamination is real and growing, with large centralized solutions not always being viable • Our decentralized solutions are CapEx efficient and deploy rapidly – US$22B market by 2021(1) (one of US$M the fastest growing segments) • 2018 Revenue of US$101.1M (+74% vs. 2017(2)) and Gross Profit US$34.5M(3) • Backlog at the end of June 2019 of US$278M • Targeting sustainably positive EBITDA by Q4 2019 (1) Source: Global Water Intelligence, Global Water Market 2017 Volume 1 (2) 2017 pro-forma (consolidation of 12 months of RWL water) 2 (3) Q4 and Full Year Audited Gross Profit include a $6.5M benefit of reversal of an onerous contract provision from prior years
Water Shortages: Widespread & Growing Global Population Water shortages affect 2.7B people now 2.4B people lack proper wastewater treatment now An additional 2.1B people need upgraded treatment Population growth from 7.4B in 2016 to 9.1B by 2050 60% increase in global food production by 2050 Manufacturing water demand will grow 400% by 2050 Experiencing Water Shortages Sufficient Water Supply Global water consumption to double by 2050 Results in 40% water deficit by 2030 Sources: WWF, Water Scarcity, 2014; US Geological Survey, 2015; UN World Water Development Report, 2017; Water for Food, UNCTAD, 2011. 3
Major Milestones and Growth Momentum Q2 2019 FY 2018 • Largest booking in Brazil for • Achieved organic $10M desalination project revenue growth of with a repeat customer Q3 2018 74% • First NIROBOX™ order in the • First MABR sale to • >200% increase in US Hubei ITEST Gross Profit • First NIROBOX™ • Reduced G&A by BOT signed in 30% Q1 2018 Philippines • Received award for Decentralized • First commercial Water & Aspiral™ sales in Wastewater US and Philippines Company of the FY 2019E Q3 2017 Year ✓ Targeting ~20% YoY • First NIROBOX™ Q1 2019 revenue growth of Emefcy and orders in Argentina Smart Products RWL Water • Record quarterly merged to form and Philippines bookings of $223M ✓ Increasing backlog of projects with Fluence • Awarded €165M Q4 2018 Recurring Revenue Corporation landmark Ivory Coast (ASX:FLC) • Commencement of contract ✓ Goal to achieve San Quintin Project sustainably positive • Largest individual order EBITDA Q2 2018 • Largest NIROBOX™ of 40 Aspiral™ units in order ever from Egypt • San Quintin China (12 units) project reaches • Official launch of SUBRE Q4 2017 Financial Close • Announcement of and first commercial Opening of first $50M Generate • Aspiral™ orders secured MABR Capital debt facility product suite • Total backlog of $267M, manufacturing plant launch up 181% YoY 4 in Changzhou, China
Complete Suite of Water & Wastewater Treatment Solutions Water Wastewater Wastewater-to- Food & Beverage Desalination Reuse Treatment Treatment Energy Processing ✓ ✓ ✓ ✓ ✓ ✓ ✓ Custom Engineered Solutions ✓ ✓ ✓ ✓ ✓ ✓ 5
Focus on Decentralized Systems Urgent Need For Affordable, Fast-to-Deploy Solutions Centralized Decentralized The vs. Rationale 2/3 of CAPEX before the plant (piping, pumping) ✓ 1/3 of time-to-complete and lower, just-in-time CAPEX Expensive to maintain and upgrade ✓ Capturing more value No flexibility and scalability ✓ Scalable and customized to fit current needs Mainly for well developed urban areas ✓ Easy to upgrade and relocate Pre-engineered plug and play • High margins solutions • Fast delivery and installation • Scalability Why Fluence Wins Proprietary smart technologies • High quality effluents and modular approach • Lower energy and OPEX • Low maintenance needs 6
Fluence Growth Areas Reporting Segment Products Smart Products Solutions Aspiral, SUBRE, NIROBOX BOOT Recurring Revenue and Complete range of O&M and Aftermarket Services Aftermarket offerings Custom-Engineered Solutions Waste-to-Energy, Large projects, EPC Water and wastewater treatment solutions for customers across the industrial, commercial and municipal sectors 7
Growth Strategy • Leading suite of Smart Products Solutions for underserved decentralized water and wastewater markets worldwide • Leverage global Custom Engineered Projects reputation on decentralized plant sales enabling more repeat orders, faster delivery, higher margin • Growing BOOT pipeline funded by non-dilutive debt finance increases recurring revenue • Target China’s wastewater treatment market with MABR-based Aspiral™ Smart Packaged plants to drive rapid growth • Leverage partners to accelerate pipeline, bookings and revenue growth • Maintain healthy top-line growth • Increase total gross margin blend • Target sustainably positive EBITDA by Q4 2019 8
Smart Products Solutions Packaged MABR wastewater treatment Packaged potable water MABR wastewater treatment solutions solutions treatment solutions for existing or new plants 5,000-200,000 GPD raw municipal 130,000-400,000 GPD Seawater, Fresh 0.15-25 MGD raw municipal sewage sewage water, Brackish water Stricter regulations Water shortages Stricter regulations Market Decentralization, Energy efficiency Decentralization, Energy-efficiency Process intensification Drivers: Increased urbanization, New-build Increased urbanization, New-build Outdated infrastructure infrastructure infrastructure Energy efficiency Plants USVI, Stanford (Title 22 Plants globally including Egypt, South Ma’ayan Zvi, Israel Market validated), Oregon, Texas, Argentina, Africa, Philippines, Caribbean, Significant and growing pipeline Adoption: Ecuador, China, Philippines, Israel Mexico, South America Commercial launch Q1 2019 and first commercial contract in Jamaica 9
Smart Products Solutions: Accelerating Activity in China Experienced local Network of Established local Reference sites in sales teams strategic partners manufacturing multiple provinces First Aspiral™ Repeat order Plant in through Jinzi Hunan Exclusive Bulk order of 35 Largest First Aspiral™ for the Local Province Jinzi secures partnership Aspiral™ units under individual order plant in Henan Government via partner third contract agreement with exclusive partnership of 40 Aspiral™ Province via of Zhenfeng Hunan in Guizhou ITEST in Hubei agreement with ITEST units from partner QSY County Kaitian Province Province in Hubei Province ITEST Sep Nov Mar May Jun Jul Oct Nov Dec Feb Mar 2017 2017 2018 2018 2018 2018 2018 2018 2018 2019 2019 First Framework First Aspiral™ Tripartite First sale via Sale of 6 Additional production agreement for 6 Plant in framework partner Hubei Aspiral™ units Aspiral™ plants of Aspiral™ Aspiral™ units via Beijing area agreement for ITEST. via partner in Hebei and modules in partner Jinzi via partner Aspiral™ in 3 Shipped, Zhongzi Huaze Zhejiang China Glory Land districts in delivered and in Jilin Province Provinces Yiyang City installed in 6 weeks 26 Partnerships covering 16 Provinces and 26 Installations 10
Recurring Revenue: Build Own Operate and Transfer (BOOT) Complete Water and Wastewater Solutions Recurring High Margin Revenue • Fluence’s Aspiral™ and NIROBOX™ products are ideal for BOOT projects → Footprint, energy efficiency, reliability, low maintenance and quality output → Using in-house proprietary technologies enhances margin • Uses Fluence’s equity to inject its own equipment • Ability to offer complete water/wastewater reuse solutions • BOOT agreements offer lucrative, recurring revenue for many years with higher valuations Multi-year Recurring Revenue Water Treatment Wastewater Treatment Capex 11
Recurring Revenue: BOOT Financing Facility in Place • Combination of equity and debt: Equity Partner – 70% non-recourse financing (Fluence) – 30% equity, and optional minority Dividend Equity Lender partners (finance Water Client Loan partner + – Fluence as EPC and O&M Contractor Fluence) Project Principal & Company Payments • Secured a US$50M non-recourse debt interest facility from Generate Capital in 2018 (SPV) Construction Payments – First drawdown of $2m in March 2019 Payments Services Operation EPC • Secured backlog of US$14.7 million of run- and (Fluence + Maintenance rate annual billings after construction of 3 contractors) (Fluence) projects is completed 12
Custom-Engineered Solutions: Solving Water and Wastewater Challenges Industrial Water Packaged Wastewater Wastewater-to-Energy Aeration Treatment Treatment Industrial Wastewater Food & Beverage EPC Projects Industrial Process Water Treatment Processing Bespoke solutions designed and built for customers worldwide 13
Custom-Engineered Solutions: Landmark Project Win in Ivory Coast • €165M commercial agreement with Federal Government of Ivory Coast, signed on February 26th, 2019 • Turnkey supply of custom-engineered solution for 150,000 m3/day surface-water treatment plant Water from Lagune Aghien will be treated to supply • The plant will treat freshwater from the naturally potable water for Abidjan contaminated Lagune Aghien and provide potable water to the city of Abidjan (4.7M population) • Fluence’s scope: water intake and treatment, bulk water piping, water towers and infrastructure • Project finance guaranteed through Export Credit Agency (ASHRA, Israel) and financed through Israel Discount Bank • Financial Close and project commencement expected later 2019 • Contract revenue expectations: US$20M in 2019, US$80M in 2020, remainder in 2021; all subject to CAD depiction of plant location and layout achievement of Financial Close by Q3 2019 14
Fluence Growth Areas: Targeted Revenue Growth Smart Products Solutions Aspiral, NIROBOX, SUBRE 2018: $22M 2019 target: $26M $101M Recurring Revenue … BOOT projects, Aftermarket $58M Custom-Engineered Solutions Large projects Wastewater-to-energy Water purification 2017 2018 Future Target Revenue Mix Shift towards higher margin proprietary solutions and recurring revenues 15
Fluence Growth Areas: Target Growing Gross Margin Increasing Gross Margin Large Smart Proprietary Proprietary Project Packaged Smart Packaged Product Plant Plant Example: >EUR165M NIROBOX™ Aspiral™ SUBRE (Ivory Coast project) 16
Outlook for Continued Growth in 2019 • ~20% year over year growth of Smart Products from $22M to $26M • Increase backlog of projects with Recurring Revenue • Achieve sustainable positive SUBRE installation, Ma’ayan Zvi, Israel EBITDA by Q4 2019 Fluence MABR manufacturing plant, Changzhou, China 17
KEY CONTACTS Key Contacts Adam Hinckley VP Investor Relations +1 914 998 3304 ahinckley@fluencecorp.com Ronn Bechler Market Eye +61 400 009 774 Ronn.Bechler@marketeye.com.au 18
Appendix
Corporate Overview Capital Structure as at 31 July 2019 ASX: FLC Top Holders ASX: FLC 31 July 2019 Shares (M) % of FLC Ordinary Shares on Issue 537.4M RSL Investments Corporation and 157.2 29.3 RSL Capital, LLC Options on issue 44.6M Share Price A$0.47 Watermark Services, LLC 47.8 8.9 Undiluted Market Capitalization A$252.6M Pond Ventures Nominees and 37.3 6.9 Richard Irving Cash at 30 June 2019 $15.6M Plan B Ventures 20.5 3.8 External debt (except non-recourse $0.8M project debt) Other top 20 108.6 20.2 Liquidity (average shares traded per day 650,377 Top 20 total 371.4 69.1 for the 3 months to 31 July 2019) Notes: • Over 58% of Fluence shares held by US entities (1) • Generate Capital $50M non-recourse debt facility, of which, only $2M has been drawn 1) As of April 1, 2019 20
World-Class Board and Leadership Management Team Board of Directors Henry J. Charrabé Tony Hargrave Richard Irving Henry J. Charrabé Managing Director & COO Chairman Managing Director & CEO • Over 30 years’ water • 35 years’ tech and CEO • Former CEO of RWL Venture Capital • Former CEO of RWL industry Water experience Water management • Over 15 years’ water • US$3B value • Over 15 years’ water experience industry experience created industry experience Francesco Fragasso Erik Arfalk Rengarajan Ramesh Ross Haghighat CFO CMO Non-executive Director Non-executive Director • 20 years’ finance • Over 15 years’ • Former CTO of • 30 years’ tech and experience in marketing strategy GE Water Venture Capital renewable energy experience • 30 years’ operating, experience and water acquisition and tech • US$4B value created treatment experience Ronen Schechter Ilan Wilf Arnon Goldfarb Paul Donnelly CTO Global VP Sales Non-executive Director Non-executive Director • Co-Founder of • Over 22 years’ water • Over 30 years’ • Over 30 years’ Emefcy industry experience industrial international • Over 25 years’ • Former VP Sales of experience financial services water technology Emefcy experience experience Adam Hinckley Spencer D. Smith Peter Marks Ross Kennedy VP Investor Relations & CLO Non-executive Director Company Secretary & Project Finance • Over 15 years of Advisor to the Board • 15 years’ as an corporate law and • 30 years’ capital • Over 30 years’ investor, advisor M&A experience markets experience experience as and sell-side • Former GC of RWL Company Secretary analyst Water 21
Global Footprint Diversifies Revenue Leverages an optimal mix of sales channels (integrators, operators, representatives, distributors, financial partners) across the key water markets 22
Large Diversified Customer Base Historical and Existing Customers and Partners Water and wastewater treatment solutions for customers across the industrial, commercial and municipal sectors 23
How MABR Works MABR - Inspired by Nature 1. Air breathed in 1. Air passes through O2 2. Oxygen Semi-permeable membrane dissolves naturally Biofilm into wastewater through membrane 2. Oxygen dissolved naturally into blood 3. Blood (with through lung material oxygen) flows out 3. Wastewater picks up oxygen to digest waste 24
Fluence’s MABR validated for California Water Recycling Standard by CR2C at Stanford • Fluence MABR demonstration unit installed Fluence MABR plant at CR2C in Stanford since January 2018 at the Codiga Resource Recovery Center (CR2C) at Stanford University • CR2C’s research validates compliance of Fluence’s MABR technology with California’s Title 22 water recycling legislation • Title 22 is among the strictest water and wastewater treatment standards for water and wastewater recycling and reuse in the United States. Additional testing parameters included enhanced nutrient removal in the form of “Total Nitrogen”. • Successful tests conducted on higher “… the system achieved the objectives of mean Total concentration of nitrogen and phosphorous Nitrogen concentrations below 10mg/L and met T22 than typical wastewater requirements as measured by Turbidity and Total Coliform in the Tertiary Effluent” - CR2C Research Report Research report available at: https://cr2c.stanford.edu/resources/software 25
Disclaimer This presentation has been prepared by Fluence Corporation Limited (ASX: FLC). All currencies quoted as “$” are US$ unless otherwise specified. This presentation may contain forward-looking statements which are identified by words such as ‘may’, ‘could’, ‘believes’, ‘estimates’, ‘targets’, ‘expects’, or ‘intends’ and other similar words that involve risks and uncertainties. These statements are based on an assessment of past and present economic and operating conditions, and on a number of assumptions regarding future events and actions that, as at the date of this presentation, are expected to take place. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, assumptions and other important factors many of which are beyond the control of the Company, its Directors and management. Although the Company believes that the expectations reflected in and the assumptions underlying the forward looking statements included in this presentation are reasonable, readers are cautioned not to place undue reliance on them, as the Company cannot give any assurance that the results, performance or achievements covered by the forward-looking statements will actually occur. This presentation should not be considered as an offer or invitation to subscribe for or purchase any shares in FLC or as an inducement to make an offer or invitation to subscribe for or purchase any shares in FLC. No agreement to subscribe for securities in the FLC will be entered into on the basis of this presentation or any information, opinions or conclusions expressed in the course of this presentation. This presentation is not a prospectus, product disclosure document or other offering document under Australian law or under the law of any other jurisdiction. It has been prepared for information purposes only and does not constitute an offer or invitation to apply for any securities, including in any jurisdiction where, or to any person to whom, such an offer or invitation would be unlawful. To the maximum extent permitted by law, the Company and its professional advisors and their related bodies corporate, affiliates and each of their respective directors, officers, management, employees, advisers and agents and any other person involved in the preparation of this presentation disclaim all liability and responsibility (including without limitation and liability arising from fault or negligence) for any direct or indirect loss or damage which may arise or be suffered through use of or reliance on anything contained in, or omitted from, this presentation. Neither the Company nor its advisors have any responsibility or obligation to update this presentation or inform the reader of any matter arising or coming to their notice after the date of this presentation document which may affect any matter referred to in the presentation. Readers should make their own independent assessment of the information and take their own independent professional advice in relation to the information and any proposed action to be taken on the basis of the information. 2018 consolidated financial figures presented on IFRS basis are audited, and after reclassifications for non-cash foreign currency adjustment relating to hyperinflation accounting in Argentina (IAS29). 26
You can also read